Top 17 Accent Therapeutics investors
The most complete profiles first. Showing 17 of 17.
David GoeddelVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Jernej GodecVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Kevin BittermanVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more
Verified email available
Krishna YeshwantVerified
Venture Capital, Corporate Venture Capital, Investor · United States
Series BHealth CareTelecommunicationsHospitalsE-commercePortfolio: Pixie, Dialpad, Science 37, Synack and 90 more
Verified email available
Peter SvennilsonVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Alex HardingVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Jason RhodesVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Karim FarisVerified
Venture Capital, Corporate Venture Capital · United States
Health CareTelecommunicationsE-commerceConsumer GoodsPortfolio: Pixie, Dialpad, Science 37, Synack and 87 more
Verified email available
Oleg NodelmanVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Sarah MarriottVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Scott PlatshonVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Tim Kutzkey
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Caroline Stout
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Contact details available
JJ Kang
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
James Evangelista
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Jean
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Steven Robinette
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Accent Therapeutics investors are on Angel Roster?
Angel Roster lists 17 Accent Therapeutics investors. 11 of them (65%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (7) and Corporate Venture Capital Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Accent Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (3) and Series B (3).
Where are Accent Therapeutics investors based?
Most are based in the United States (17).
Which companies have Accent Therapeutics investors backed?
The most-backed portfolio companies among them are Remix Therapeutics (11), Surface Oncology (10), Intellia Therapeutics (10), Magenta Therapeutics (10) and Scorpion Therapeutics (10).
How do I contact Accent Therapeutics investors?
Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.